KPF
KIN

K2 Principal Fund’s Kindred Biosciences, Inc. KIN Stock Holding History

K2 Principal Fund’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,458
Closed -$133K – 519
2021
Q2 		$133K Buy
+14,458
New +$84.1K 0.01% 327

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

K2 Principal Fund's KIN Position: Q3 2021 in Review

K2 Principal Fund sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 14,458 shares — an estimated $133K sold.

K2 Principal Fund first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $133K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • K2 Principal Fund reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • K2 Principal Fund sold 14,458 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $133K.
  • K2 Principal Fund first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • K2 Principal Fund's Kindred Biosciences, Inc. position peaked at $133K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on K2 Principal Fund's 13F filing for Q3 2021, filed 12 Nov 2021.